Mentholatum Co

A Message from Lord Pickles and Lord Blunkett, followed by Mentholatum Co's best practice article

The ability to listen and learn from one another has always been vital in parliament, in business and in most aspects of daily life. But at this particular moment in time, as national and global events continue to reiterate, it is uncommonly crucial that we forge new channels of communication and reinforce existing ones. The following article from Mentholatum Co is an attempt to do just that. We would welcome your thoughts on this or any other Parliamentary Review article.

Blunkett signature Rt Hon The Lord David Blunkett
Pickles signature Rt Hon The Lord Eric Pickles

www.mentholatum.co.uk

55MENTHOLATUM CO |
BEST PRACTICE REPRESENTATIVE 2018
Rob Yateman, managing director
The Mentholatum Company’s UK
headquarters at East Kilbride
The Mentholatum Company blends knowledge gained over
more than a century with trailblazing scientific research
and consumer insights to create innovative, 21st-century
products to treat changing healthcare needs. From its origins
in Kansas in the 19th century, it is now the UK’s number one
seller of topical pain relief products and the name behind iconic
brands such as Deep Heat and Deep Freeze. Speaking on its
behalf is its managing director, Rob Yateman.
The company began in Wichita, Kansas, in 1889 and the UK company was
established in 1924. With strong links to Japan, where the Mentholatum founders
sourced the menthol used in their products, the company was acquired by the
Rohto Pharmaceutical Company in 1998. However, the Mentholatum Group works
independently and autonomously. There are five specific teams at the company’s
UK headquarters at East Kilbride, Scotland:
»Research and quality development
»Finance, logistics and HR
»Production
»Sales
»Marketing
Our long history and success in pain relief means our products are known and
recognised throughout the world, but in today’s competitive market it is essential
to listen to consumers and retailers. That is why we place such importance on a
programme of research which helps us develop new products, formats and delivery
FACTS ABOUT
MENTHOLATUM CO
»Managing director: Rob
Yateman
»Established in Wichita, Kansas,
in 1889 with a UK subsidiary
set up in 1924. The company
was acquired by the Japanese
Rohto Pharmaceutical
Company in 1998, but
operates independently
»Based in East Kilbride,
Scotland
»Services: The research,
development, manufacture
and marketing of topical pain
relief products, including Deep
Heat, and other personal care
brands
»No. of employees: 100
»The original Mentholatum
Ointment was used by
cowboys to help relieve aches
and pains after long days in
the saddle
Mentholatum Co
THE PARLIAMENTARY REVIEW
Highlighting best practice
56 | MENTHOLATUM CO
systems designed to meet changing
consumer needs.
Today’s sedentary lifestyles and
obesity are increasingly leading to
low back pain, which alone costs the
UK economy an estimated £12billion
per year. As manufacturers, we must
bring to market effective, 21st-
century solutions to emerging 21st-
centuryproblems.
Working with universities
Collaboration with Scottish universities
– via sports scientists at the University
of Stirling and through funding PhD
students at the University of Edinburgh
– gives Mentholatum the chance to
use state-of-the-art equipment and
groundbreaking research to acquire
a deeper understanding of the effect
our topical pain relief products have on
soft tissue.
At Stirling, data from a first-of-its-kind
study into the depth of penetration
of topical products on deep tissue
has allowed us to demonstrate the
effectiveness of products applied
to the skin, and the university has
published the data in peer-reviewed
journals as well as presenting the
findings at international scientific
conferences.
Mentholatum has a long-standing
relationship with Edinburgh University
through its funding of PhD students.
This has given us exclusive access
to pioneering medical imaging
techniques, and recent investigations
– the first of their kind conducted
anywhere in the world – have given
insights into the changes in deeper
soft tissue structures and temperature
when our products are applied to
theskin.
This collaboration will allow us to use
the data to strengthen commercial
claims and increase sales. It will help
us better understand how to optimise
our formulations and also identify
innovations for the next generation of
products.
The clinical application of these
developing technologies has
benefited other researchers studying
degenerative brain disorders, liver
disease and other systems of the body.
Meeting demand for
innovation
To meet the dual demand for drug-free
products which are also user-friendly,
our latest innovations are a “Deep
Heat” muscle massage lotion and
“Deep Freeze” pain relief gel, which
are applied using rollerball technology
more usually seen in the deodorant
sector. The new delivery system means
hard-to-reach places can be treated
without touching the lotion or gel.
The factory at East Kilbride is a
modern, high-quality facility, where
a product can go from concept to
prototype and into production on
the same site. Our plant produces
20 million tubes of Deep Heat, Deep
Freeze and Deep Relief every year.
Award-winning Deep
Relief – winner of a
Pharmacy Product of the
Year award for the past
five years
As
manufacturers,
we must bring
to market
effective,
21st-century
solutions to
emerging
21st-century
problems
57MENTHOLATUM CO |
BEST PRACTICE REPRESENTATIVE 2018
Connecting with retailers and
consumers
In order to keep up with current
needs, it is important to connect
with both the pharmacies and other
outlets which stock the products and
the consumers who buy them. This is
done with ongoing PR activity and the
products are also supported via social
media and digital, radio, TV and print
advertising.
Our commitment to retailers and
consumers has been recognised
with a slew of industry awards. The
prestigious OTC Awards recognise
excellence in over-the-counter
medicines and therapeutic products.
We have won six OTC Marketing
Awards for innovation, marketing and
packaging since 2012. In addition,
Deep Relief, our triple-action, anti-
inflammatory gel, has won Pharmacy
Product of the Year awards in five
successive years.
One of our biggest successes recently
is our award-winning work with
marathon runners. We promote
our brands to them but, equally
importantly, connect with runners
via social media and online running
platforms to help them through their
training. On race days, our billboards
at the start and along the route are
designed to help the runners keep
going with inspirational messages.
Mentholatum believes that, wherever
possible, people should play an active
role in their own healthcare. With this
in mind, we have launched “Mind
Your Back”, a national, multimedia
health campaign to help people
manage back pain and prevent future
problems with a simple five-step plan
involving stretching, therapy, exercise,
posture and strengthening.
Our goal is caring for the nation,
using knowledge gained over more
than a century combined with the
latest scientific research and consumer
insights to make Mentholatum the
company which consistently delivers
effective, affordable, accessible
products.
We are committed to continuing to
research and develop products to help
relieve the muscle and joint pain which
affects millions of people in the UK
and throughout the world. We are
looking forward to an exciting, active
future for the Mentholatum team and
our customers.
Our plant
produces
20million tubes
of Deep Heat,
Deep Freeze
and Deep Relief
every year
Mind Your Back is a
national campaign
to help prevent and
manage back pain

www.mentholatum.co.uk

This article was sponsored by Mentholatum Co. The Parliamentary Review is wholly funded by the representatives who write for it. The publication in which this article originally appeared contained the following foreword from The Rt Hon Theresa May MP.

The Rt Hon Theresa May MP's Foreword For The Parliamentary Review

By The Rt Hon Theresa May MP

This foreword from the then Prime Minister appeared in the 2018/19 Parliamentary Review.

British politics provides ample material for analysis in the pages of The Parliamentary Review. For Her Majesty’s Government, our task in the year ahead is clear: to achieve the best Brexit deal for Britain and to carry on our work to build a more prosperous and united country – one that truly works for everyone. 

The right Brexit deal will not be sufficient on its own to secure a more prosperous future for Britain. We also need to ensure that our economy is ready for what tomorrow will bring. Our Modern Industrial Strategy is our plan to do that. It means Government stepping up to secure the foundations of our productivity: providing an education system that delivers the skills our economy needs, improving school standards and transforming technical education; delivering infrastructure for growth; ensuring people have the homes they need in the places they want to live. It is all about taking action for the long-term that will pay dividends in the future.

But it also goes beyond that. Government, the private sector and academia working together as strategic partners achieve far more than we could separately. That is why we have set an ambitious goal of lifting UK public and private research and development investment to 2.4 per cent of GDP by 2027. It is why we are developing four Grand Challenges, the big drivers of social and economic change in the world today: harnessing artificial intelligence and the data revolution; leading in changes to the future of mobility; meeting the challenges of our ageing society; and driving ahead the revolution in clean growth. By focusing our efforts on making the most of these areas of enormous potential, we can develop new exports, grow new industries and create more good jobs in every part of our country.

Years of hard work and sacrifice from the British people have got our deficit down by over three quarters. We are building on this success by taking a balanced approach to public spending. We are continuing to deal with our debts, so that our economy can remain strong and we can protect people’s jobs, and at the same time we are investing in vital public services, like our NHS. We have set out plans to increase NHS funding annually by an average by 3.4 percent in real terms: that is £394 million a week more. In return, the NHS will produce a ten-year plan, led by doctors and nurses, to eliminate waste and improve patient care.

I believe that Britain can look to the future with confidence. We are leaving the EU and setting a new course for prosperity as a global trading nation. We have a Modern Industrial Strategy that is strengthening the foundations of our economy and helping us to seize the opportunities of the future. We are investing in the public services we all rely on and helping them to grow and improve. Building on our country’s great strengths – our world-class universities and researchers, our excellent services sector, our cutting edge manufacturers, our vibrant creative industries, our dedicated public servants – we can look towards a new decade that is ripe with possibility. The government I lead is doing all it can to make that brighter future a reality for everyone in our country. 

British politics provides ample material for analysis in the pages of The Parliamentary Review 
The Rt Hon Theresa May MP
Prime Minister